S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
NASDAQ:UTMD

Utah Medical Products Stock Forecast, Price & News

$111.56
+0.30 (+0.27%)
(As of 11/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$108.79
$113.97
50-Day Range
$87.77
$124.71
52-Week Range
$81.01
$133.87
Volume
16,891 shs
Average Volume
10,276 shs
Market Capitalization
$407.31 million
P/E Ratio
28.98
Dividend Yield
1.02%
Beta
0.23
30 days | 90 days | 365 days | Advanced Chart
Receive UTMD News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.


Utah Medical Products logo

About Utah Medical Products

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.

Headlines

Utah Medical Products declares $2.00 special dividend
November 2, 2021 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:UTMD
CUSIP
91748810
Employees
181
Year Founded
N/A

Sales & Book Value

Annual Sales
$42.18 million
Cash Flow
$5.30 per share
Book Value
$28.25 per share

Profitability

Net Income
$10.80 million
Pretax Margin
36.04%

Debt

Price-To-Earnings

Miscellaneous

Free Float
3,391,000
Market Cap
$407.31 million
Optionable
Not Optionable

Company Calendar

Ex-Dividend
9/15/2021
Dividend Payable
10/05/2021
Last Earnings
10/26/2021
Today
12/01/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
1/27/2022

MarketRank

Overall MarketRank

1.63 out of 5 stars

Medical Sector

1081st out of 1,390 stocks

Surgical & Medical Instruments Industry

109th out of 127 stocks

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 1.7Insider Behavior: 2.5Valuation: 0.0 5 -4 -3 -2 -1 -












Utah Medical Products (NASDAQ:UTMD) Frequently Asked Questions

How has Utah Medical Products' stock price been impacted by COVID-19?

Utah Medical Products' stock was trading at $88.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, UTMD stock has increased by 26.1% and is now trading at $111.56.
View which stocks have been most impacted by COVID-19
.

When is Utah Medical Products' next earnings date?

Utah Medical Products is scheduled to release its next quarterly earnings announcement on Thursday, January 27th 2022.
View our earnings forecast for Utah Medical Products
.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) issued its earnings results on Tuesday, October, 26th. The medical instruments supplier reported $1.15 earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $12.57 million for the quarter. Utah Medical Products had a net margin of 29.22% and a trailing twelve-month return on equity of 13.40%.
View Utah Medical Products' earnings history
.

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products announced a None dividend on Tuesday, November 2nd. Stockholders of record on Wednesday, December 15th will be given a dividend of $2.00 per share on Wednesday, December 29th. The ex-dividend date is Tuesday, December 14th.
View Utah Medical Products' dividend history
.

Is Utah Medical Products a good dividend stock?

Utah Medical Products pays an annual dividend of $1.14 per share and currently has a dividend yield of 1.02%. Utah Medical Products has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Utah Medical Products is 29.61%. This payout ratio is at a healthy, sustainable level, below 75%.
View Utah Medical Products' dividend history.

Who are Utah Medical Products' key executives?

Utah Medical Products' management team includes the following people:
  • Kevin Leighton Cornwell, Chairman, President, CEO & Secretary
  • Brian Lee Koopman, Chief Financial Officer & Controller
  • Paul Olson Richins, Director

What is Kevin L. Cornwell's approval rating as Utah Medical Products' CEO?

8 employees have rated Utah Medical Products CEO Kevin L. Cornwell on Glassdoor.com. Kevin L. Cornwell has an approval rating of 43% among Utah Medical Products' employees. This puts Kevin L. Cornwell in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG), Walt Disney (DIS), UnitedHealth Group (UNH), Intuitive Surgical (ISRG), Altria Group (MO), SEI Investments (SEIC), Trupanion (TRUP), Visa (V), Ventas (VTR) and Axon Enterprise (AAXN).

What is Utah Medical Products' stock symbol?

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

Who are Utah Medical Products' major shareholders?

Utah Medical Products' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (6.31%), BlackRock Inc. (5.92%), Dimensional Fund Advisors LP (4.16%), Rice Hall James & Associates LLC (3.15%), Russell Investments Group Ltd. (2.11%) and Geode Capital Management LLC (1.54%). Company insiders that own Utah Medical Products stock include Barbara A Payne, Barbara A Payne, Ernst G Hoyer and Kevin L Cornwell.
View institutional ownership trends for Utah Medical Products
.

Which major investors are selling Utah Medical Products stock?

UTMD stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, BlackRock Inc., Russell Investments Group Ltd., Clean Yield Group, California State Teachers Retirement System, Dimensional Fund Advisors LP, Seizert Capital Partners LLC, and Geode Capital Management LLC. Company insiders that have sold Utah Medical Products company stock in the last year include Barbara A Payne, and Ernst G Hoyer.
View insider buying and selling activity for Utah Medical Products
or view top insider-selling stocks.

Which major investors are buying Utah Medical Products stock?

UTMD stock was purchased by a variety of institutional investors in the last quarter, including HealthInvest Partners AB, Martingale Asset Management L P, First Quadrant L P CA, SG Americas Securities LLC, Rice Hall James & Associates LLC, Everett Harris & Co. CA, Metropolitan Life Insurance Co NY, and Barclays PLC.
View insider buying and selling activity for Utah Medical Products
or or view top insider-buying stocks.

How do I buy shares of Utah Medical Products?

Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Utah Medical Products' stock price today?

One share of UTMD stock can currently be purchased for approximately $111.56.

How much money does Utah Medical Products make?

Utah Medical Products has a market capitalization of $407.31 million and generates $42.18 million in revenue each year. The medical instruments supplier earns $10.80 million in net income (profit) each year or $3.85 on an earnings per share basis.

How many employees does Utah Medical Products have?

Utah Medical Products employs 181 workers across the globe.

What is Utah Medical Products' official website?

The official website for Utah Medical Products is www.utahmed.com.

Where are Utah Medical Products' headquarters?

Utah Medical Products is headquartered at 7043 South 300 West, Midvale UT, 84047.

How can I contact Utah Medical Products?

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The medical instruments supplier can be reached via phone at (801) 566-1200 or via fax at 801-566-7305.


This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.